Human Reproduction Update Advance Access published online on September 19, 2005
Human Reproduction Update, doi:10.1093/humupd/dmi037
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Obstetrics, Gynecology and Neonatology, Fondazione ‘Policlinico-Mangiagalli-Regina Elena’, Milan, Italy
* To whom correspondence should be addressed. Although population-based studies have unequivocally reported an increased risk of ovarian cancer in women with endometriosis, the biological evidence supporting the idea of endometriosis as a preneoplastic condition is scanty and not well substantiated. The fundamental features of human neoplasms (monoclonal growth, genetic changes, mutations in tumour suppressor genes and replicative advantage) have been evaluated in endometriotic lesions but results obtained are discordant. It is plausible that ectopic glands may expand monoclonally but the entity of this phenomenon is debated. According to some allelotyping studies, from one-third to one-half of endometriosis lesions would harbour somatic genetic changes in chromosomal regions supposed to contain genes involved in ovarian tumourigenesis, especially for the endometrioid histotype. These findings would be consistent with the progression model for carcino-genesis from the benign precursor to ovarian cancer but they could not be unequivocally replicated. Gene mutational studies are rare in this context. A single group has found missense mutations and deletions of PTEN gene in about 20% of ovarian endometriotic cysts. Moreover, in a model of genetically engineered mice harbouring an oncogenic allele of K-ras resulting in benign lesions reminiscent of endometriosis, a conditional deletion of PTEN caused the progression towards the endometrioid tumour. Based on these data, the causal link between endometriosis and ovarian endometrioid/clear cell carcinomas remains to be defined both in terms of entity of association and of undelying molecular mechanisms.
Received June 1, 2005
Accepted July 29, 2005
Article
Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis
Paola Viganó, E-mail: paola.vigano{at}unimi.it
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Laudanski, J. Szamatowicz, O. Kowalczuk, M. Kuzmicki, M. Grabowicz, and L. Chyczewski Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis Hum. Reprod., August 1, 2009; 24(8): 1880 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Borghese, F. Mondon, J.-C. Noel, I. Fayt, T.-M. Mignot, D. Vaiman, and C. Chapron Research Resource: Gene Expression Profile for Ectopic Versus Eutopic Endometrium Provides New Insights into Endometriosis Oncogenic Potential Mol. Endocrinol., November 1, 2008; 22(11): 2557 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Somigliana, P. Panina-Bordignon, S. Murone, P. Di Lucia, P. Vercellini, and P. Vigano Vitamin D reserve is higher in women with endometriosis Hum. Reprod., August 1, 2007; 22(8): 2273 - 2278. [Abstract] [Full Text] [PDF]
|
|